Wesley Parker, MD
Orthopaedic Surgery · Greer, SCNPI 1508350646
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (60.0%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Smith+Nephew at 55.4% of the total. Reporting peaked in 2024 at $9,874 and has fallen 95.4% since, to $450 in 2025.
Across 70 payments — averaging $455.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$18K
- Peerless Surgical Inc.$12K
- Zimmer Biomet$2K
- Johnson & Johnson$126
- Amgen$123
- Vericel Corporation$22
- plus $56 from 3 others
What the payments were for
- Grants$7,50024%
- Travel & lodging$2,6888%
- Food & beverage$2,5728%
- Education$19,12060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 23 | $17,660 |
| Peerless Surgical Inc. | 13 | $11,738 |
| Zimmer Biomet | 24 | $2,155 |
| Johnson & Johnson(2 entities) | 5 | $126 |
| Amgen | 1 | $123 |
| Vericel Corporation | 1 | $22 |
| Osteoremedies, LLC | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Bioventus LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$2,790
- Legion Revision$1,151
- OR3O Dual Mobility$1,151
- RI.HIP NAVIGATION$1,151
- JOURNEY$1,151
- Affixus$991
- REAL INTELLIGENCE$251
- NCB$150
- ROSA$145
- Persona$145
- Tandem$141
- EVENITY$123
How this compares
$31,880 in reported general payments places this provider in the 85th percentile of 325 orthopaedic surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 103 | $1,043 |
| Celecoxib | 14 | $145 |
| Methylprednisolone | 24 | $142 |
| Oxycodone Hcl | 22 | $94 |
| Mupirocin | 12 | $72 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $68 |
| Meloxicam | 29 | $55 |
| Tramadol Hcl | 20 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Greer
- Nathanael AdamsGreer$22K
- William SmithColumbia$7.7M
- Richard FrischMt Pleasant$1M
- Brent PonceCharleston$874K
- Chi LimSpartanburg$320K
- Todd LansfordNorth Charleston$286K
- Nicholas GrimaldiColumbia$203K
- Richard MarksWest Columbia$176K
- James LogingClinton$118K
- Justin SmithRock Hill$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.